# EDGAR Filing Document

**Accession Number:** 0001290677
**File Stem:** 0001437749-26-006974
**Filing Date:** 2026-3
**Character Count:** 11074
**Document Hash:** deddd4dd3dcb54e88876726acbab4699
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-006974.hdr.sgml**: 20260305

**ACCESSION NUMBER**: 0001437749-26-006974

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260302

**FILED AS OF DATE**: 20260305

**DATE AS OF CHANGE**: 20260305

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Cushman Brittani
- **CENTRAL INDEX KEY:** 0001831600

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37763
- **FILM NUMBER:** 26724065

**MAIL ADDRESS:**
- **STREET 1:** 5201 INTERCHANGE WAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40229
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Turning Point Brands, Inc.
- **CENTRAL INDEX KEY:** 0001290677
- **STANDARD INDUSTRIAL CLASSIFICATION:** TOBACCO PRODUCTS [2100]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 133961898
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 5201 INTERCHANGE WAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40229
- **BUSINESS PHONE:** (502) 778-4421

**MAIL ADDRESS:**
- **STREET 1:** 5201 INTERCHANGE WAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40229

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** North Atlantic Holding Company, Inc.
- **DATE OF NAME CHANGE:** 20040517

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Cushman Brittani<br><sub>(Last) (First) (Middle)</sub><br>5201 INTERCHANGE WAY<br><sub>(Street)</sub><br>LOUISVILLE, KY 40229<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Sr VP, General Counsel_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Turning Point Brands, Inc. [ TPB ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 406.806 | I | By Spouse<sup>(1)</sup> |
| Common Stock | 2026-03-02 |  | A |  | 4782 | A | $108.51 | 38863<sup>(9)</sup> | D |  |
| Common Stock | 2026-03-02 |  | A |  | 668 | A | $108.51 | 39531<sup>(10)</sup> | D |  |
| Common Stock | 2026-03-02 |  | A |  | 10700 | A | $108.51 | 50231<sup>(11)</sup> | D |  |
| Common Stock | 2026-03-02 |  | A |  | 1632 | A | $108.51 | 51863<sup>(12)</sup> | D |  |
| Common Stock | 2026-03-02 |  | A |  | 615 | A | $108.51 | 52478<sup>(13)</sup> | D |  |
| Common Stock | 2026-03-02 |  | F |  | 6057 | D | $108.51 | 46421<sup>(14)</sup> | D |  |
| Common Stock | 2026-03-02 |  | F |  | 1192 | D | $108.51 | 45229<sup>(15)</sup> | D |  |
| Common Stock | 2026-03-03 |  | A |  | 2181 | A | $107.57 | 47410<sup>(16)</sup> | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Options<sup>(8)</sup> | $30.4600 |  |  |  |  |  |  | <sup>(7)</sup> | 2032-03-14 | Common Stock | 8000 |  | 8000 | D |  |
| Options<sup>(2)</sup> | $51.7500 |  |  |  |  |  |  | <sup>(3)</sup> | 2031-02-18 | Common Stock | 7000 |  | 7000 | D |  |
| Options<sup>(2)</sup> | $14.8500 |  |  |  |  |  |  | <sup>(4)</sup> | 2030-03-18 | Common Stock | 3000 |  | 3000 | D |  |
| Options<sup>(2)</sup> | $47.5800 |  |  |  |  |  |  | <sup>(5)</sup> | 2029-03-20 | Common Stock | 4800 |  | 4800 | D |  |
| Options<sup>(2)</sup> | $21.2100 |  |  |  |  |  |  | <sup>(6)</sup> | 2028-03-07 | Common Stock | 500 |  | 500 | D |  |

---

### Footnotes:

(1) The reporting person disclaims beneficial ownership of these securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.

(2) Granted pursuant to the issuer's 2015 Equity Incentive Plan

(3) The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024.

(4) The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023.

(5) The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022.

(6) The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.

(7) The options vest and become exercisable as to 34% of the underlying shares on January 1, 2023, 33% of the underlying shares on January 1, 2024 and 33% of the underlying shares on January 1, 2025.

(8) Granted pursuant to the issuer's 2021 Equity Incentive Plan.

(9) Reports common stock issued upon settlement of performance restricted units granted to the reporting person in February 2021. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 8,609 restricted stock units and 30,254 shares of common stock.

(10) Reports common stock issued upon settlement of performance restricted units granted to the reporting person in March 2022. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 8,609 restricted stock units and 30,922 shares of common stock.

(11) Reports common stock issued upon settlement of performance restricted units granted to the reporting person in May 2023. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 8,609 restricted stock units and 41,622 shares of common stock.

(12) Reports common stock issued upon settlement of performance restricted units granted to the reporting person in March 2024. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 8,609 restricted stock units and 43,254 shares of common stock.

(13) Reports common stock issued upon settlement of performance restricted units granted to the reporting person in March 2025. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 8,609 restricted stock units and 43,869 shares of common stock.

(14) The reported transaction involves shares withheld for the payment of taxes related to performance restricted stock units that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 8,609 restricted stock units and 37,812 shares of common stock.

(15) The reported transaction involves shares withheld for the payment of taxes related to the person's receipt of grants of restricted stock units under Turning Point Brands, Inc.'s 2021 Equity Incentive Plan. The total reported in Column 5 includes 7,417 restricted stock units and 37,812 shares of common stock.

(16) The reported transaction involved the reporting person's receipt of a grant of 2,181 restricted stock units under Turning Point Brands, Inc,'s 2021 Equity Incentive Plan. The total reported in Column 5 includes 9,598 restricted stock units and 37,812 shares of common stock (this includes 8,716 shares of common stock deferred into the Company Non-Qualified Deferred Plan, which will be settled in accordance with the terms thereof).

**Signature:** /s/ Brittani Cushman  
**Date:** 2026-03-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**